- Home
- BNTX vs SBAC Comparison
BNTX vs SBAC Comparison
Compare BNTX & SBAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- SBAC
- Stock Information
- Founded
- BNTX 2008
- SBAC 1989
- Country
- BNTX Germany
- SBAC United States
- Employees
- BNTX N/A
- SBAC N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- SBAC Real Estate Investment Trusts
- Sector
- BNTX Health Care
- SBAC Real Estate
- Exchange
- BNTX Nasdaq
- SBAC Nasdaq
- Market Cap
- BNTX 26.4B
- SBAC 20.2B
- IPO Year
- BNTX 2019
- SBAC 1999
- Fundamental
- Price
- BNTX $106.05
- SBAC $197.30
- Analyst Decision
- BNTX Strong Buy
- SBAC Buy
- Analyst Count
- BNTX 14
- SBAC 15
- Target Price
- BNTX $138.99
- SBAC $244.13
- AVG Volume (30 Days)
- BNTX 655.5K
- SBAC 950.6K
- Earning Date
- BNTX 11-03-2025
- SBAC 11-03-2025
- Dividend Yield
- BNTX N/A
- SBAC 2.23%
- EPS Growth
- BNTX N/A
- SBAC 71.76
- EPS
- BNTX N/A
- SBAC 8.15
- Revenue
- BNTX $3,380,387,551.00
- SBAC $2,724,524,000.00
- Revenue This Year
- BNTX N/A
- SBAC $6.88
- Revenue Next Year
- BNTX $11.89
- SBAC $2.72
- P/E Ratio
- BNTX N/A
- SBAC $24.21
- Revenue Growth
- BNTX 6.98
- SBAC 1.82
- 52 Week Low
- BNTX $81.20
- SBAC $185.45
- 52 Week High
- BNTX $129.27
- SBAC $245.17
- Technical
- Relative Strength Index (RSI)
- BNTX 55.87
- SBAC 51.03
- Support Level
- BNTX $103.20
- SBAC $194.38
- Resistance Level
- BNTX $108.05
- SBAC $199.87
- Average True Range (ATR)
- BNTX 3.03
- SBAC 3.73
- MACD
- BNTX 0.22
- SBAC 1.46
- Stochastic Oscillator
- BNTX 57.78
- SBAC 81.81
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About SBAC SBA Communications Corporation
SBA Communications owns a portfolio of about 45,000 wireless towers throughout North America, South America, and Africa. It leases space on its towers to wireless service providers, who install equipment to support their wireless networks. The company has a very concentrated customer base, with most revenue in each market being generated by the top few mobile carriers. It owns more than 17,000 towers in the US, which account for about 75% of leasing revenue. Internationally, SBA's largest presence is in Brazil, where it owns roughly 10,000 towers. SBA operates as a real estate investment trust.